Cystic Fibrosis Rare Variant Analysis, One Exon

Test Code
10913


CPT Codes
81221

Physician Attestation of Informed Consent
This germline genetic test requires physician attestation that patient consent has been received if ordering medical facility is located in AK, DE, FL, GA, IA, MA, MN, NV, NJ, NY, OR, SD or VT or test is performed in MA.


Preferred Specimen
4 mL whole blood collected in an EDTA (lavender-top or royal blue-top) or ACD (yellow-top) or sodium heparin (green-top) tube


Minimum Volume
3 mL whole blood • 3 ml amniotic fluid, chorionic villi, or culture amniocytes • 10 mg biopsy


Other Acceptable Specimens
5 mL amniotic fluid, chorionic villi, cultured amniocytes collected in a T-25 flask • 20 mg chorionic villus biopsy


Instructions
Please indicate ethnicity of the patient.

-Whole blood (preferred): Normal phlebotomy procedure. Specimen stability is crucial. Store and ship ambient immediately. Do not freeze.
-For prenatal diagnosis with a fetal specimen: 1) parents must be documented carriers of one of the mutations tested; 2) maternal blood or DNA must be available; 3) contact the laboratory genetic counselor before submission.
-Amniotic fluid: Normal collection procedure. Specimen stability is crucial. Store and ship ambient immediately. Do not refrigerate or freeze.
-Amniocyte culture: Sterile T25 flask, filled with culture medium. Specimen stability is crucial. Store and ship ambient immediately. Do not refrigerate or freeze.
-Dissected chorionic villus (CVS) biopsy: 10-20 mg dissected chorionic villi collected in sterile tube filled with sterile culture media. Specimen stability is crucial. Store and ship ambient immediately. Do not refrigerate or freeze.


Transport Temperature
Room temperature


Specimen Stability
Whole blood (preferred)
Room temperature: 14 days
Refrigerated: 14 days
Frozen: Unacceptable

Amniotic or chorionic villi
Room temperature: 8 days
Refrigerated: Unacceptable
Frozen: Unacceptable


Methodology
Next Generation Sequencing

FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Setup Schedule
Setup: As needed; Report available: 7 weeks after set up


Reference Range
See Laboratory Report


Clinical Significance
Cystic fibrosis (CF) is the most common recessive lethal genetic disorder affecting primarily Caucasians of Northern European descent, with an incidence of approximately 1 in 3300 births and a carrier rate of 1 in 29. Detection of variant in one exon is useful in patients with a known familial variant that is not included in the general cystic fibrosis mutation panel.




The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.